Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 6/20 | 0.50 |
| ▸ | HTR2C | P28335 | 6/20 | 0.50 |
| ▸ | HTR2B | P41595 | 6/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 5/20 | 0.50 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.42 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.42 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.42 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.42 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.42 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.42 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.41 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.41 |
| ▸ | KDM1A | O60341 | 4/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29723594 | 1.00 | HTR2A (0.50) | HTR2AHTR2CHTR2BHRH3GRIN2D | |
| Ammonia Solution, Strong SCHEMBL2786789 | 0.98 | HTR2A (0.49) | HTR2AHTR2CHTR2BHRH3GRIN2D | |
| Hydrochloric Acid SCHEMBL8521423 | 0.96 | HTR2A (0.50) | HTR2AHTR2CHTR2BHRH3GRIN2D | |
| Bromide SCHEMBL7360884 | 0.96 | HTR2A (0.47) | HTR2AHTR2CHTR2BHRH3GRIN2D | |
| Hydrochloric Acid SCHEMBL7424402 | 0.96 | HTR2A (0.50) | HTR2AHTR2CHTR2BHRH3GRIN2D | |
| Acetamide SCHEMBL4960612 | 0.85 | HTR2A (0.44) | HTR2AHTR2CHTR2BHRH3SIGMAR1 | |
| SCHEMBL11328530 | 0.83 | HTR2A (0.50) | HTR2AHTR2CHTR2BHRH3SIGMAR1 | |
| SCHEMBL352937 | 0.79 | SIGMAR1 (0.47) | HTR2AHTR2CHTR2BHRH3GRIN2D | |
| 4-Dimethylaminophenol SCHEMBL17609160 | 0.79 | HTR2A (0.46) | HTR2AHTR2CHTR2BHRH3SIGMAR1 | |
| SCHEMBL28392676 | 0.78 | HTR2A (0.39) | HTR2AHTR2CHTR2BHRH3SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9403936-B2 | Method for preparing a pitch for carbon fibers and a pitch for carbon fibers prepared by the same | GS CALTEX CORPORATION (KR) | 2016-08-02 | — | — | US | disclosed |
| US-20160090441-A1 | METHOD FOR PREPARING A PITCH FOR CARBON FIBERS AND A PITCH FOR CARBON FIBERS PREPARED BY THE SAME | GS CALTEX CORPORATION (KR) | 2016-03-31 | — | — | US | disclosed |
| US-20140346085-A1 | METHOD OF PREPARING PITCH FOR CARBON FIBER | GS CALTEX CORPORATION (KR) | 2014-11-27 | — | — | US | disclosed |
| US-20100105894-A1 | Cyclopropane compounds and pharmaceutical use thereof | JAPAN TOBACCO INC. | 2010-04-29 | — | — | US | disclosed |
| EP-1694410-B1 | CYCLOPROPANE DERIVATIVES AND PHARMACEUTICAL USE THEREOF | JAPAN TOBACCO INC (JP) | 2010-04-14 | — | — | EP | disclosed |
| US-20080306258-A1 | Cyclopropane compounds and pharmaceutical use thereof | JAPAN TOBACCO INC. | 2008-12-11 | — | — | US | disclosed |
| US-20080261994-A1 | CYCLOPROPANE COMPOUNDS AND PHARMACEUTICAL USE THEREOF | JAPAN TOBACCO INC. | 2008-10-23 | — | — | US | disclosed |
| US-20080242656-A1 | N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof | JAPAN TOBACCO INC. | 2008-10-02 | — | — | US | disclosed |
| WO-2008051382-A2 | METHOD OF MAKING A SOLVENT FROM RUBBER TIRES | NATURAL RESOURCE RECOVERY, INC. (US) | 2008-05-02 | — | — | WO | disclosed |
| US-20080096787-A1 | from waste tires comprising heating tire particles in an enclosures to generate hydrocarbon vapors rich in limonene and naphthalene, and carbon black solids | NATURAL RESOURCE RECOVERY, INC. | 2008-04-24 | — | — | US | disclosed |
| US-7351825-B2 | Cyclopropane compounds and pharmaceutical use thereof | JAPAN TOBACCO INC. (JP) | 2008-04-01 | — | — | US | disclosed |
| WO-2007079133-A2 | SYSTEM AND METHOD FOR RECYCLING WASTE INTO ENERGY | NATURAL RESOURCE RECOVERY, INC. (US) | 2007-07-12 | — | — | WO | disclosed |
| US-20060199826-A1 | Cyclopropane compounds and pharmaceutical use thereof | JAPAN TOBACCO INC. (JP) | 2006-09-07 | — | — | US | disclosed |
| EP-1476433-B1 | NOVEL TRICYCLOIMIDAZOLINE DERIVATIVES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENTS | PF MEDICAMENT (FR) | 2005-11-09 | — | — | EP | disclosed |
| US-20050107455-A1 | Novel tricycloimidazoline derivatives method for production and use thereof as medicaments | PIERRE FABRE MEDICAMENT (FR) | 2005-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050107455-A1 | Novel tricycloimidazoline derivatives method for production and use thereof as medicaments | CYP4F3, HRH4, SLCO1B3 | HTR2A 1947/4885HTR2C 497/4885HTR2B 1178/4885 |
| US-20080242656-A1 | N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof | MMP13, MMP11, MMP3 | HTR2A 1494/4885HTR2C 1355/4885HTR2B 1115/4885 |
| US-20060199826-A1 | Cyclopropane compounds and pharmaceutical use thereof | MMP13, MMP9, MMP11 | HTR2A 1214/4885HTR2C 1790/4885HTR2B 1338/4885 |
| US-20080261994-A1 | CYCLOPROPANE COMPOUNDS AND PHARMACEUTICAL USE THEREOF | MMP13, MMP9, MMP11 | HTR2A 1246/4885HTR2C 1820/4885HTR2B 1358/4885 |
| US-20100105894-A1 | Cyclopropane compounds and pharmaceutical use thereof | MMP13, MMP9, MMP11 | HTR2A 1246/4885HTR2C 1820/4885HTR2B 1358/4885 |
| US-20080306258-A1 | Cyclopropane compounds and pharmaceutical use thereof | MMP13, MMP9, MMP11 | HTR2A 1329/4885HTR2C 1881/4885HTR2B 1438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.